Double-blind clinical trial with rifampicin versus ampicillin in the control of chronic bacteriuria.
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use*; D001437:Bacteriuria / Q000188:drug therapy* / Q000382:microbiology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011512:Proteus Infections / Q000188:drug therapy; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use*
D010919:Placebos; D000667:Ampicillin; D012293:Rifampin